about
New therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future.Targeted therapies in neuroendocrine tumors (NET): clinical trial challenges and lessons learnedSulfonylurea receptor as a target for molecular imaging of pancreas beta cells with (99m)Tc-DTPA-glipizide.Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Role of everolimus in pancreatic neuroendocrine tumors.
@en
Role of everolimus in pancreatic neuroendocrine tumors.
@nl
type
label
Role of everolimus in pancreatic neuroendocrine tumors.
@en
Role of everolimus in pancreatic neuroendocrine tumors.
@nl
prefLabel
Role of everolimus in pancreatic neuroendocrine tumors.
@en
Role of everolimus in pancreatic neuroendocrine tumors.
@nl
P2860
P356
P1476
Role of everolimus in pancreatic neuroendocrine tumors.
@en
P2093
Robert Goldstein
P2860
P304
P356
10.1586/ERA.11.145
P577
2011-09-20T00:00:00Z